AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024

Rhea-AI Summary

AngioDynamics, Inc. (ANGO) will report Q3 fiscal year 2024 financial results on April 4, 2024, followed by a conference call. Investors can access the call via phone or webcast on the company's website.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the third quarter of fiscal year 2024 before the market open on Thursday, April 4, 2024. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results.

To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and refer to the passcode 13745239.

This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available from 10:00 a.m. ET on Thursday, April 4, 2024, until 11:59 p.m. ET on Thursday, April 11, 2024. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13745239.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240319173188/en/

Investor Contact:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When will AngioDynamics report Q3 fiscal year 2024 financial results?

AngioDynamics will report Q3 fiscal year 2024 financial results on April 4, 2024.

How can investors participate in the conference call?

Investors can participate in the conference call by dialing 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and referring to the passcode 13745239.

Where can the conference call be accessed?

The conference call can be accessed from the 'Investors' section of the AngioDynamics website at www.angiodynamics.com.

How long will the webcast replay of the call be available?

The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

When will the recording of the call be available?

The recording of the call will be available from 10:00 a.m. ET on Thursday, April 4, 2024, until 11:59 p.m. ET on Thursday, April 11, 2024.